EurekAlert! -
22 Aug 2017 06:00
(University of Pennsylvania School of Medicine) Researchers found a relationship between the genetics of tumors with germline BRCA1/2 mutations and whether the tumor retains the normal copy of the BRCA1/2 gene, and risk for primary resistance to a common chemotherapy that works by destroying cancer cells' DNA.
Share this Article